# Phasorz Technologies Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phasorz-technologies-private

- Industry: Healthcare IT
- Headquarters: Bangalore, India
- Website: www.medibuddy.in/
- Total disclosed funding: $121M
- Latest round: Series F (Feb 28, 2022)
- Investors on record: 11

## About

Phasorz Technologies Private Limited, based in India, specializes in delivering innovative healthcare solutions that enhance access to medical services through its MediBuddy platform, providing convenience for users seeking comprehensive health management.Phasorz Technologies Private Limited, founded in 2013, operates the MediBuddy platform which offers a range of health services. Headquartered in Bangalore, India, the company has successfully secured a total of INR 22.5 million in Series F funding from Stride Ventures in June 2022, bringing their total amount raised to INR 22.5 million and current company valuation to INR 29,938.36 million. The company's founders include Enbasekar D, Satish Kannan, and Yogesh R, with Satish Kannan currently serving as CEO. The company has participated in 12 total deals since its inception.MediBuddy provides a wide array of healthcare solutions designed to facilitate access to medical services for individuals and families. Core offerings encompass online doctor consultations, lab test bookings, medication delivery, and health insurance support, addressing various health-related needs. The platform also allows real-time claim tracking and issues e-cards for cashless hospital visits, significantly enhancing user experience. Target customers range from individuals seeking convenient healthcare solutions to families needing coordinated care and corporate clients integrating health services for their employees. MediBuddy extends its operations to urban centers and regions with limited access to traditional healthcare facilities.In the most recent fiscal year of 2023, MediBuddy reported a revenue of INR 37,096,931.80 and an EBITDA of -INR 35,449,237. Revenue is generated through a combination of direct-to-consumer and B2B models, where clients utilize the platform for doctor consultations and lab tests, with payments processed on-site. Furthermore, the collaboration with health insurance providers enables users to manage their claims effectively. The revenue structure includes service packages and membership plans for regular users, alongside one-time fees for individual consultations or lab tests, contributing to customer loyalty.Looking ahead, Phasorz Technologies aims to expand its product offerings and geographical presence. Recent funding from the Series F round will be directed towards developing new services and enhancing the existing platform. The company plans to target expansion into additional urban markets across India by the end of 2023, as part of its growth strategy following its latest deal in June 2022.

## Funding rounds

- Series F, Feb 28, 2022, $89M — Bessemer Venture Partners, JIF Capital, Rebright Partners, FinSight Ventures, InvAscent Capital Partners, Zenith Investment
- Series E, Jan 8, 2021, $10M — InvAscent Capital Partners
- Series E, Nov 4, 2020, $8M — JIF Capital, FinSight Ventures, ALES Global
- Series E, May 16, 2020, $7M — Bessemer Venture Partners, Rebright Partners, FinSight Ventures, Milliways Ventures, Fusian Capital
- Series C, Oct 16, 2017, $6M — Bessemer Venture Partners, DeNA, Rebright Partners, Milliways Ventures, TechMatrix Corporation
- Seed, Mar 1, 2016, $1M — Rebright Partners

## Investors

- Rebright Partners (https://capitalatlas.ai/funds/rebright-partners) — Seed, Series C, Series E, Series F
- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series C, Series E, Series F
- DeNA — Series C
- Milliways Ventures (https://capitalatlas.ai/funds/milliways-ventures) — Series C, Series E
- TechMatrix Corporation — Series C
- FinSight Ventures (https://capitalatlas.ai/funds/finsight-ventures) — Series E, Series F
- Fusian Capital (https://capitalatlas.ai/funds/fusian-capital) — Series E
- JIF Capital (https://capitalatlas.ai/funds/jif-capital) — Series E, Series F
- ALES Global (https://capitalatlas.ai/funds/ales-global) — Series E
- InvAscent Capital Partners (https://capitalatlas.ai/funds/invascent-capital-partners) — Series E, Series F
- Zenith Investment — Series F